Clovis Oncology's cancer drug Rubraca succeeds in key study

loading...


Clovis Oncology’s cancer drug Rubraca succeeds in key study
(Reuters) – Clovis Oncology Inc said its ovarian cancer drug Rubraca slowed disease progression in patients who had undergone initial treatment in a late-stage trial, paving the way for expanding the use of the therapy.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...